Achieving Forecasting And Inventory Agility In Modern Clinical Supply Chains

By Laura Hay, senior director, global program management at Trax Group | 2025 Winner, everywoman Customer/Passenger (Leader) Award

In clinical supply chains, forecasting and inventory management are about far more than operational efficiency. They directly influence patient access, study continuity, regulatory compliance, and overall trial success.

As clinical trials become increasingly global, decentralized, and patient-centric, supply teams face growing pressure to balance product availability with inventory optimization. The challenge is no longer simply forecasting demand — it's forecasting uncertainty.

The organizations that are succeeding today are moving beyond static planning models and embracing more agile data-driven approaches that improve visibility, responsiveness, and decision-making throughout the clinical supply chain.

The Forecasting Challenge In Clinical Trials

Unlike commercial supply chains, clinical demand is rarely predictable.

Enrollment timelines shift. Patient recruitment varies by region. Protocol amendments occur unexpectedly. Study expansion, site activation delays, and patient discontinuation rates can all significantly impact supply requirements.

As a result, clinical supply teams are constantly balancing two critical risks:

• Overstocking investigational product that may expire or go unused
• Understocking critical materials that could impact patient treatment or study timelines

Neither outcome is ideal, and both carry significant financial and operational consequences. Traditional forecasting methods that rely heavily on historical assumptions often struggle to keep pace with the dynamic nature of modern clinical trials.

Connecting Forecasting And Inventory Planning

One of the biggest opportunities within clinical supply chains is improving the connection between forecasting and inventory management. Too often, these functions operate independently.

Forecasting teams focus on projected patient demand, while inventory teams focus on product availability and distribution requirements. When those functions are disconnected, organizations can find themselves making decisions based on incomplete information. True supply chain agility occurs when enrollment forecasts, site demand, inventory positions, manufacturing schedules, and logistics data are viewed as part of a single ecosystem. When supply teams have access to real-time information across these areas, they can make faster, more informed decisions as trial conditions change.

Moving Toward Predictive Planning

Clinical supply chains generate significant amounts of data, yet many organizations still rely on manual processes and static planning cycles.

The next evolution is predictive planning. By leveraging real-time operational data, organizations can identify patterns and emerging risks earlier, allowing supply teams to proactively adjust inventory strategies before disruptions occur. Examples include:

• anticipating enrollment surges in specific regions
• identifying potential depot shortages
• adjusting supply allocations based on recruitment trends
• planning manufacturing activities more effectively
• improving site-level inventory management.

The objective is not simply creating more accurate forecasts — it is creating forecasts that can adapt as study conditions evolve.

Inventory Agility Across Global Clinical Networks

Inventory agility is becoming increasingly important as studies expand across multiple countries and patient populations. Holding excess inventory everywhere is costly and inefficient. Holding too little inventory introduces significant risk. Leading organizations are focusing on creating inventory strategies that provide both flexibility and control. This includes:

• improved depot inventory visibility
• dynamic allocation strategies
• better management of expiration timelines
• more responsive resupply models
• stronger alignment between demand forecasts and inventory positioning.

The goal is ensuring the right product is available in the right location at the right time without creating unnecessary waste.

Reducing Waste While Protecting Patients

One of the most significant challenges in clinical supply chains is balancing patient availability with inventory utilization. Unused investigational product represents more than a financial loss. It reflects manufacturing capacity, logistics resources, and operational effort that could potentially be deployed elsewhere.

Improved forecasting and inventory visibility can help organizations:

• reduce product expiration
• minimize excess inventory
• improve redistribution opportunities
• optimize manufacturing schedules
• strengthen overall study efficiency.

Most importantly, it helps ensure patients receive uninterrupted access to treatment throughout the study life cycle.

Visibility As The Foundation Of Agility

Forecasting and inventory optimization are only as effective as the visibility supporting them. Clinical supply teams need access to accurate, timely information regarding:

• inventory levels
• site demand
• shipment status
• enrollment trends
• manufacturing schedules
• depot activity.

Without visibility, planning becomes reactive. With visibility, organizations can identify risks earlier and respond before they impact study operations.

The Future Of Clinical Supply Planning

The future of clinical supply chains will be defined by agility. As trial designs become more complex and patient expectations continue to evolve, organizations must move beyond static planning processes and toward integrated, intelligence-driven supply chain strategies.

Success will depend on the ability to connect forecasting, inventory management, logistics, and operational data into a unified decision-making framework, because in today's clinical environment, forecasting is no longer just about predicting demand. It's about building the flexibility and visibility needed to respond when that demand inevitably changes.

About The Author:

Laura Hay is a global supply chain leader specializing in program management, customer success, and account strategy. She has a proven track record of leading cross-functional teams to deliver complex, high-impact initiatives on time and within budget. Laura is known for building strong stakeholder relationships, driving operational excellence, and managing multimillion-dollar programs. She is passionate about connecting people, processes, and technology to build scalable, resilient supply chain solutions that deliver measurable business impact.